Education
About Us
Working with TipRanks
Follow Us
Vicarious Surgical (RBOT)
NYSE:RBOT
RBOT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.00 - $19.00
Previous CloseN/A
Volume30.88K
Average Volume (3M)36.32K
Market Cap
$36.37M
Enterprise Value$33.77M
Total Cash (Recent Filing)$23.96M
Total Debt (Recent Filing)$13.20M
Price to Earnings (P/E)―
Beta2.40
Next Earnings
Nov 10, 2025EPS Estimate
-2.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.23
Shares Outstanding5,298,253
10 Day Avg. Volume36,227
30 Day Avg. Volume36,321
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue16.16
Enterprise Value/Gross Profit-138.41
Enterprise Value/Ebitda-0.57
Forecast
1Y Price Target
$10.00Price Target Upside63.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
Leadership And StrategyA new CEO with over 20 years of leadership in the healthcare and financial industry has been appointed, bringing valuable experience to lead the company through its current development and clinical programs.
Product DevelopmentRBOT successfully built its first patient cart and surgeon console for formal preclinical testing.
Regulatory ProgressRBOT is planning to submit a technical dossier that will enable treatment of first clinical patients, significantly boosting investor sentiment.
Bears Say
Development DelaysDevelopment milestones and timelines were shifted back 3 to 6 months due to supplier dynamics which have limited key parts within the Vicarious System.
Financial ChallengesRBOT's capital position remains its biggest challenge as RBOT exited with ~$24.0M in cash and continues to expect ~$50M in cash burn for FY25 forcing RBOT to make some tough decisions.
Product Development PauseThe company will hold off on its clinical trial initiation in order to further develop its system to be 'product ready', indicating a pause until further notice.
Vicarious Surgical News
RBOT FAQ
What was Vicarious Surgical’s price range in the past 12 months?
Vicarious Surgical lowest stock price was $5.00 and its highest was $19.00 in the past 12 months.
What is Vicarious Surgical’s market cap?
Vicarious Surgical’s market cap is $36.37M.
When is Vicarious Surgical’s upcoming earnings report date?
Vicarious Surgical’s upcoming earnings report date is Nov 10, 2025 which is in 70 days.
How were Vicarious Surgical’s earnings last quarter?
Vicarious Surgical released its earnings results on Aug 12, 2025. The company reported -$2.23 earnings per share for the quarter, beating the consensus estimate of -$2.497 by $0.267.
Is Vicarious Surgical overvalued?
According to Wall Street analysts Vicarious Surgical’s price is currently Undervalued.
Does Vicarious Surgical pay dividends?
Vicarious Surgical does not currently pay dividends.
What is Vicarious Surgical’s EPS estimate?
Vicarious Surgical’s EPS estimate is -2.33.
How many shares outstanding does Vicarious Surgical have?
Vicarious Surgical has 5,298,253 shares outstanding.
What happened to Vicarious Surgical’s price movement after its last earnings report?
Vicarious Surgical reported an EPS of -$2.23 in its last earnings report, beating expectations of -$2.497. Following the earnings report the stock price went down -24.348%.
Which hedge fund is a major shareholder of Vicarious Surgical?
Currently, no hedge funds are holding shares in RBOT
Vicarious Surgical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (63.67% Upside)
$10.00 (63.67% Upside)
Insider Transactions
Sold Shares
Worth $40.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 13.2%
Last 30 Days ▲ 13.2%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.71%
12-Months-Change
Fundamentals
Return on Equity
-125.63%
Trailing 12-Months
Asset Growth
-56.20%
Trailing 12-Months
Company Description
Vicarious Surgical
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
RBOT Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a company undergoing significant leadership transition and strategic reassessment. While there are positives in the form of reduced operating expenses and net loss, major challenges remain, particularly around delays in clinical trials and resource constraints. The uncertainty in achieving future milestones further complicates the outlook.View all RBOT earnings summariesRBOT Stock 12 Month Forecast
Average Price Target
$10.00
▲(63.67% Upside)
Technical Analysis
Ownership Overview
39.64% Insiders
3.87% Mutual Funds
28.64% Other Institutional Investors
25.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---